Solventum Corp Q3 FY25 Results

Summary

Solventum reported a 0.7% increase in sales to $2.1 billion for the third quarter of 2025, with organic sales growing by 2.7%. The company's GAAP diluted earnings per share were $7.22, and adjusted diluted earnings per share were $1.50. Solventum has increased its full-year outlook for organic sales growth and adjusted earnings per share. The company also announced a new multiyear initiative, 'Transform for the Future', aimed at reshaping its cost structure and enhancing operational efficiency, expecting $500 million in annual cost savings.

Key Highlights

1. 1

   Solventum's sales increased by 0.7% to $2.1 billion in the third quarter of 2025, with organic sales up by 2.7%.

2. 2

   GAAP diluted earnings per share were $7.22, while adjusted diluted earnings per share reached $1.50 for Q3 2025.

3. 3

   The company expects full-year organic sales growth to be at the high end of the +2.0% to +3.0% range.

4. 4

   Solventum increased its full-year adjusted earnings per share outlook to $5.98 to $6.08.

5. 5

   Operating income margin was 80.6%, and adjusted operating income margin was 20.6% for the third quarter.

6. 6

   Net income for the quarter was $1,266 million, a significant increase compared to $122 million in the same period last year.

7. 7

   Solventum launched 'Transform for the Future', a 4-year initiative expected to generate approximately $500 million in annual cost savings.